beta-amyrin has been researched along with Colitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bento, AF; Calixto, JB; Claudino, RF; Marcon, R; Matos, I | 1 |
| Bento, AF; Calixto, JB; Figueiredo, CP; Hara, DB; Mazzuco, TL; Vitor, CE | 1 |
2 other study(ies) available for beta-amyrin and Colitis
| Article | Year |
|---|---|
Preventive and therapeutic oral administration of the pentacyclic triterpene α,β-amyrin ameliorates dextran sulfate sodium-induced colitis in mice: the relevance of cannabinoid system.
Topics: Administration, Oral; Amidohydrolases; Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Asialoglycoproteins; Body Weight; Cannabinoids; CD18 Antigens; Cell Adhesion Molecules; Chemokines; Colitis; Colon; Dextran Sulfate; Intercellular Adhesion Molecule-1; Interleukin-1beta; Interleukin-4; Ki-67 Antigen; Lectins, C-Type; Male; Membrane Proteins; Mice; Oleanolic Acid; P-Selectin; Peroxidase; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; RNA, Messenger; Tumor Necrosis Factor-alpha; Up-Regulation; Vascular Cell Adhesion Molecule-1 | 2013 |
Therapeutic action and underlying mechanisms of a combination of two pentacyclic triterpenes, alpha- and beta-amyrin, in a mouse model of colitis.
Topics: Animals; Colitis; Disease Models, Animal; Drug Therapy, Combination; Male; Mice; Oleanolic Acid; Pentacyclic Triterpenes; Trinitrobenzenesulfonic Acid | 2009 |